J. Biochem, 1990, Vol. 107, No. 5 718-725
© 1990 Japanese Biochemical Society
research-article |
Purification and Characterization of Four Catalytically Active Testosterone 6ß-Hydroxylase P-450s from Rat Liver Microsomes: Comparison of a Novel Fprm with Three structurally and Functionally Related Forms1
*Department of Pharmacology, School of Medicine, Keio University Shinjuku-Ku, Tokyo 160
**Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health Bethesda, MD 20892, U. S.A.
2 To whom correspondence should be addressed.
Four microsomal cytochrome P– 450s (P-450), all of which are active testosterone 6ß -hydroxylases, were purified to electrophoretic homogeneity from livers of phenobarbital-treated (P- 4506ß-2 and P-4506ß-3) or dexamethasone-treated adult male rats (P-4506ß1 and P-4506ß-4). Purified P-4506ß-1, P-4506ß-2, P-4506ß-3, and P-4506ß-4 had apparent molecular weights of 52,000, 51,000, 52,000, and 52,500 as assessed by sodium dodecyl sulfate -polyacrylamide gel electrophoresis. Absolute spectra revealed that all four P-450 forms had characteristic low-spin spectral patterns in their fully oxidized states. P-4506ß-2 and P-4506ß 3 displayed spectra of the reduced carbonyl complex with 
max at 447 nm. P-4506ß2 and P-4506ß-4 showed max at 446 and 448 nm, respectively. Antibodies raised against each P-450 recognized all forms, although differences were observed with respect to the extents of cross-reactivities on Western blots. Form-specific peptide fragments were also detected among the four P-450 proteins after partial protease-digestion. P-4506ß1was identical to P-4506ß-3 in the first 26 residues of the NH2terminal amino acid sequence, but differed by 13 residues from P-4506ß-2. The amino-terminal sequence of P-4506ß-2 was unique and was not identical with those of any rat P-450 previously reported. This P-450 form was detected in the livers of untreated male rats and was induced by treatment with dexamethasone, but not with phenobarbital. All four purified preparations catalyzed testosterone 6/9-hydroxylation in a reconstituted system containing cytochrome £%, extracted microsomal lipids and sodium cholate. Rates of hydroxylation were 35.3, 23.7, 13.8, and 0. 6 nmol/min/ nmol P-450, respectively, with P-4506ß-1, P-4506ß -2, P-4506ß-3, and P-4506ß-4. In addition, all antibodies against each of the four P-4506ß-2, forms inhibited more than 90% of the formation of 6/ 5-hydroxytestosterone in hepatic microsomes of untreated rats. These results indicate that at least four distinct yet structurally related forms of P-450, including a new form, P– 4505ß -2> exist in rat livers, and all of them catalyze testosterone 6ß -hydroxylation.
1 This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science and Culture of Japan and a Grant-in-Aid from the Japan Health Science Foundation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Miyata, H. Takano, L. Q. Guo, K. Nagata, and Y. Yamazoe Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity Carcinogenesis, February 1, 2004; 25(2): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamamoto, N. Hagima, M. Nakamura, Y. Kohno, K. Nagata, and Y. Yamazoe Differences in Cytochrome P450 Forms Involved in the Metabolism of N,N-Dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a Novel Sigma Ligand, in Human Liver and Intestine Drug Metab. Dispos., January 1, 2003; 31(1): 60 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kawai, S. M. Bandiera, T. K. H. Chang, F. M. Poulet, P. M. Vancutsem, and G. D. Bellward Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen Drug Metab. Dispos., December 1, 1999; 27(12): 1392 - 1398. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. M. Huss and C. B. Kasper Nuclear Receptor Involvement in the Regulation of Rat Cytochrome P450 3A23 Expression J. Biol. Chem., June 26, 1998; 273(26): 16155 - 16162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Iwatsubo, H. Suzuki, N. Shimada, K. Chiba, T. Ishizaki, C. E. Green, C. A. Tyson, T. Yokoi, T. Kamataki, and Y. Sugiyama Prediction of in Vivo Hepatic Metabolic Clearance of YM796 from in Vitro Data by Use of Human Liver Microsomes and Recombinant P-450 Isozymes J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 909 - 919. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Carlin, P. Christofalo, B. H. Arison, R. E. Ellsworth, A. Rosegay, R. R. Miller, S. H. L. Chiu, and W. J. A. Vandenheuvel Disposition and Metabolism of Finasteride in Dogs Drug Metab. Dispos., January 1, 1997; 25(1): 100 - 109. [Abstract] [Full Text]
|
|